RecruitingNot ApplicableNCT07500012

taVNS for Breast Cancer Pain and Symptom Management

Home-based Pain and Symptom Management for Breast Cancer Survivors: a Triple- Blinded RCT Pilot Study of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)


Sponsor

Florida State University

Enrollment

40 participants

Start Date

Feb 24, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

1. To evaluate the feasibility and acceptability of a home-based taVNS intervention and follow-up for pain and symptom management in breast cancer survivors. 2. To investigate the impact of taVNS on secondary outcomes, including pain, anxiety, depression, fatigue, and the brain-gut axis (BGA) in breast cancer survivors.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 79 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Active taVNS and a medical device called Sham taVNS for people with breast cancer survivors. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEActive taVNS

practice the active taVNS twice daily for 30 minutes each over a 4-week period (56 sessions)

DEVICESham taVNS

practice the sham taVNS twice daily for 30 minutes each over a 4-week period (56 sessions)


Locations(1)

Florida State University

Tallahassee, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07500012


Related Trials